Evolus (EOLS) Non-Current Deferred Tax Liability (2017 - 2026)

Evolus (EOLS) reported Non-Current Deferred Tax Liability of $23000.0 for Q1 2026, up 1050.0% on a YoY basis from $2000.0 in Q1 2025, and down 17.86% quarter-over-quarter from $28000.0 in Q4 2025.

Evolus (EOLS) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends

Evolus has reported Non-Current Deferred Tax Liability for 10 years, with the latest figure at $23000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Deferred Tax Liability rose 1050.0% year-over-year to $23000.0; the trailing twelve-month figure through Mar 2026 stood at $23000.0 (up 1050.0% YoY), and the FY2025 full-year result was $28000.0, up 366.67% from the prior year.
  • Non-Current Deferred Tax Liability for Q1 2026 stood at $23000.0, down from $28000.0 in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $12.4 million in Q4 2022, with the low at $2000.0 in Q1 2025.
  • Historically, Non-Current Deferred Tax Liability has averaged $1.4 million across 5 years, with a median of $24000.0 in 2022.
  • Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability slumped 99.93% — and 2026, when it surged 1050.0%.
  • Evolus' Non-Current Deferred Tax Liability stood at $12.4 million in 2022, then fell by 25.68% to $9.2 million in 2023, then tumbled by 99.93% to $6000.0 in 2024, then jumped by 366.67% to $28000.0 in 2025, then retreated by 17.86% to $23000.0 in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $23000.0 (Q1 2026), $28000.0 (Q4 2025), and $21000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Evolus 435.45 Mn 385.65 Mn 48.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 23,000.00
Mar 31, 2026 23,000.00
Dec 31, 2025 28,000.00
Dec 31, 2025 28,000.00
Jun 30, 2025 21,000.00
Jun 30, 2025 21,000.00
Mar 31, 2025 2,000.00
Mar 31, 2025 2,000.00
Dec 31, 2024 6,000.00
Dec 31, 2024 6,000.00
Sep 30, 2024 29,000.00
Sep 30, 2024 29,000.00
Jun 30, 2024 29,000.00
Jun 30, 2024 29,000.00
Mar 31, 2024 32,000.00
Mar 31, 2024 32,000.00
Dec 31, 2023 9.19 Mn
Dec 31, 2023 9.19 Mn
Sep 30, 2023 22,000.00
Sep 30, 2023 22,000.00